Schedule of Recast of Selected Unaudited Consolidated Statements of Income and Comprehensive Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended February 28, 2018
|
|
|
As Previously
|
|
|
|
|
In millions, except per share amounts
|
|
Reported
|
|
Adjustments
|
|
As Adjusted
|
Service revenue
|
|
$
|
848.4
|
|
$
|
69.6
|
|
$
|
918.0
|
Operating expenses
|
|
|
270.7
|
|
|
1.5
|
|
|
272.2
|
Selling, general and administrative expenses
|
|
|
303.3
|
|
|
(8.4)
|
|
|
294.9
|
Total expenses
|
|
|
574.0
|
|
|
(6.9)
|
|
|
567.1
|
Operating income
|
|
|
292.5
|
|
|
76.5
|
|
|
369.0
|
Income taxes
|
|
|
34.4
|
|
|
(30.3)
|
|
|
4.1
|
Net income
|
|
$
|
260.4
|
|
$
|
106.8
|
|
$
|
367.2
|
Basic earnings per share
|
|
$
|
0.72
|
|
$
|
0.30
|
|
$
|
1.02
|
Diluted earnings per share
|
|
$
|
0.72
|
|
$
|
0.29
|
|
$
|
1.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine months ended February 28, 2018
|
|
|
As Previously
|
|
|
|
|
In millions, except per share amounts
|
|
Reported
|
|
Adjustments
|
|
As Adjusted
|
Service revenue
|
|
$
|
2,464.0
|
|
$
|
22.2
|
|
$
|
2,486.2
|
Operating expenses
|
|
|
751.5
|
|
|
1.3
|
|
|
752.8
|
Selling, general and administrative expenses
|
|
|
788.6
|
|
|
1.2
|
|
|
789.8
|
Total expenses
|
|
|
1,540.1
|
|
|
2.5
|
|
|
1,542.6
|
Operating income
|
|
|
969.7
|
|
|
19.7
|
|
|
989.4
|
Income taxes
|
|
|
270.6
|
|
|
(51.5)
|
|
|
219.1
|
Net income
|
|
$
|
705.2
|
|
$
|
71.2
|
|
$
|
776.4
|
Basic earnings per share
|
|
$
|
1.96
|
|
$
|
0.20
|
|
$
|
2.16
|
Diluted earnings per share
|
|
$
|
1.95
|
|
$
|
0.20
|
|
$
|
2.15
|
|
Schedule of Recast of Selected Unaudited Consolidated Statement of Cash Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine months ended February 28, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASU No.
|
|
ASU No.
|
|
|
|
|
|
As Previously
|
|
2014-09
|
|
2016-18
|
|
|
|
In millions
|
|
Reported
|
|
Adjustments
|
|
Adjustments
|
|
As Adjusted
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
705.2
|
|
$
|
71.2
|
|
$
|
—
|
|
$
|
776.4
|
Amortization of deferred contract costs
|
|
$
|
—
|
|
$
|
130.5
|
|
$
|
—
|
|
$
|
130.5
|
Provision/(benefit) for deferred income taxes
|
|
$
|
6.5
|
|
$
|
(51.5)
|
|
$
|
—
|
|
$
|
(45.0)
|
Accounts receivable
|
|
$
|
(6.2)
|
|
$
|
(21.6)
|
|
$
|
—
|
|
$
|
(27.8)
|
Accounts payable and other current liabilities
|
|
$
|
80.9
|
|
$
|
0.5
|
|
$
|
—
|
|
$
|
81.4
|
Deferred costs
|
|
$
|
—
|
|
$
|
(128.5)
|
|
$
|
—
|
|
$
|
(128.5)
|
Net change in other long-term assets and liabilities
|
|
$
|
3.4
|
|
$
|
(0.6)
|
|
$
|
—
|
|
$
|
2.8
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in funds held for clients' money market securities and
other cash equivalents
|
|
$
|
(409.1)
|
|
$
|
—
|
|
$
|
409.1
|
|
$
|
—
|
Net cash provided by investing activities
|
|
$
|
24.4
|
|
$
|
—
|
|
$
|
409.1
|
|
$
|
433.5
|
Increase in cash, cash equivalents, restricted
cash and restricted cash equivalents
|
|
$
|
139.3
|
|
$
|
—
|
|
$
|
409.1
|
|
$
|
548.4
|
Cash, cash equivalents, restricted cash and restricted cash
equivalents, beginning of fiscal year
|
|
$
|
184.6
|
|
$
|
—
|
|
$
|
264.8
|
|
$
|
449.4
|
Cash, cash equivalents, restricted cash and restricted
cash equivalents, end of period
|
|
$
|
323.9
|
|
$
|
—
|
|
$
|
673.9
|
|
$
|
997.8
|
|
Schedule of Recast of Selected Unaudited Consolidated Statement of Cash Flow |
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended August 31, 2018
|
|
|
As Previously
|
|
|
|
|
|
In millions
|
|
Reported
|
|
Adjustments
|
|
As Revised
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
Net change in funds held for clients’ money market securities and other cash equivalents
|
|
$
|
762.5
|
|
$
|
(762.5)
|
|
$
|
—
|
Net cash provided by investing activities
|
|
$
|
918.5
|
|
$
|
(762.5)
|
|
$
|
156.0
|
Increase/(decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
|
|
$
|
81.9
|
|
$
|
(762.5)
|
|
$
|
(680.6)
|
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of fiscal year
|
|
$
|
358.2
|
|
$
|
1,942.3
|
|
$
|
2,300.5
|
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period
|
|
$
|
440.1
|
|
$
|
1,179.8
|
|
$
|
1,619.9
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents to the Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
|
$
|
440.1
|
Restricted cash and restricted cash equivalents included in funds held for clients
|
|
|
|
|
|
|
|
|
1,179.8
|
Total cash, cash equivalents, restricted cash and restricted cash equivalents
|
|
|
|
|
|
|
|
$
|
1,619.9
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months ended November 30, 2018
|
|
|
As Previously
|
|
|
|
|
|
In millions
|
|
Reported
|
|
Adjustments
|
|
As Revised
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
Net change in funds held for clients’ money market securities and
other cash equivalents
|
|
$
|
985.1
|
|
$
|
(985.1)
|
|
$
|
—
|
Net cash provided by investing activities
|
|
$
|
1,038.8
|
|
$
|
(985.1)
|
|
$
|
53.7
|
Increase/(decrease) in cash, cash equivalents, restricted
cash and restricted cash equivalents
|
|
$
|
152.4
|
|
$
|
(985.1)
|
|
$
|
(832.7)
|
Cash, cash equivalents, restricted cash and restricted cash
equivalents, beginning of fiscal year
|
|
$
|
358.2
|
|
$
|
1,942.3
|
|
$
|
2,300.5
|
Cash, cash equivalents, restricted cash and restricted
cash equivalents, end of period
|
|
$
|
510.6
|
|
$
|
957.2
|
|
$
|
1,467.8
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of cash, cash equivalents, restricted cash and restricted cash
equivalents to the Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
|
$
|
510.6
|
Restricted cash and restricted cash equivalents included in funds held for clients
|
|
|
|
|
|
|
|
|
957.2
|
Total cash, cash equivalents, restricted cash and restricted cash equivalents
|
|
|
|
|
|
|
|
$
|
1,467.8
|
|